A detailed history of Jnba Financial Advisors transactions in Celcuity Inc. stock. As of the latest transaction made, Jnba Financial Advisors holds 38,091 shares of CELC stock, worth $588,505. This represents 0.07% of its overall portfolio holdings.

Number of Shares
38,091
Previous 38,091 -0.0%
Holding current value
$588,505
Previous $822,000 24.21%
% of portfolio
0.07%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$11.96 - $19.35 $88,575 - $143,306
7,406 Added 24.14%
38,091 $502,000
Q3 2021

Nov 10, 2021

BUY
$17.35 - $24.87 $172,059 - $246,635
9,917 Added 47.75%
30,685 $552,000
Q4 2018

Feb 07, 2019

BUY
$20.87 - $29.05 $433,428 - $603,310
20,768 New
20,768 $498,000
Q3 2018

Nov 01, 2018

SELL
$20.96 - $30.77 $113,812 - $167,081
-5,430 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$11.94 - $14.29 $64,834 - $77,594
5,430
5,430 $66,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $231M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.